| Literature DB >> 22456519 |
Abstract
In physiological systems, for every "yang," there must be a "yin," for uncontrolled systems can run amok. This is the case for the T-cell compartment of the immune system, where activation must be modulated, dampened, and ultimately reversed; to not apply the brakes leads to dire consequences. In less than 20 years, CTLA-4 has emerged from being an orphan, next becoming a physiological star with ever-emerging effects, and finally to being a therapeutic target-an impressive example of evolution and one that continues. Understanding the costimulatory effects and mechanisms of CTLA-4 and the redundancies intrinsic to costimulation is important in understanding T-cell function and dysfunction in disease. A future article in this series will describe inducible T-cell costimulator, which is a normal by-pass to CTLA-4's effects.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22456519 DOI: 10.1097/RHU.0b013e31824ea103
Source DB: PubMed Journal: J Clin Rheumatol ISSN: 1076-1608 Impact factor: 3.517